Morgan Stanley Raises Price Target on Integra LifeSciences to $27 From $24, Keeps Underweight Rating
Morgan Stanley Raises Price Target on Integra LifeSciences to $27 From $24, Keeps Underweight Rating
大摩資源lof將英特格拉生命科學的目標股價從24美元上調至27美元，仍然保持減持評級。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊